actc

Advanced Cell Technology pub: Trial for Macular Degeneration

ACT-FIgure-1-

The stem cell biotech Advanced Cell Technology (ACT) reported new, positive data in a paper in Lancet from their clinical trials using retinal pigmented epithelial cells (RPEs) made from human embryonic stem cells (hESC) for treatment of different forms of macular degeneration (MD). The paper was entitled “Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related …

Advanced Cell Technology pub: Trial for Macular Degeneration Read More »

ACT’s Bob Lanza Does the #IceBucketChallenge

Robert-Lanza

Before I did the #icebucketchallenge, I challenged the leader of Advanced Cell Technology (ACT), Dr. Bob Lanza, to do the Ice Bucket Challenge. He did it and leading up to it he provided a quite articulate message for context (see video below). Bob is one very cool guy even without ice water. The purpose of the …

ACT’s Bob Lanza Does the #IceBucketChallenge Read More »

Interview with Bob Lanza on new ACT MSCs for MS paper

I did a brief email Q&A interview with Dr. Bob Lanza of Advanced Cell Technology (ACT) on their new hES MSCs pre-clinical data for Multiple Sclerosis. I discussed the paper itself in a concise review yesterday here. Thanks to Dr. Lanza for doing the interview. 1. Were you surprised at the fact that the therapeutic …

Interview with Bob Lanza on new ACT MSCs for MS paper Read More »

Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS

advanced-cell-technology

There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of …

Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »

Adult human therapeutic cloning of embryonic stem cells by SCNT

Human-SCNT1

An international team of stem cell scientists has replicated human therapeutic cloning to make embryonic stem cells via somatic cell nuclear transfer (SCNT). The team was led by Drs. Dong Ryul Lee of CHA Stem Cell Institute in Korea and Robert Lanza of Advanced Cell Technology (ACT) and reported the advance in the Chung, et …

Adult human therapeutic cloning of embryonic stem cells by SCNT Read More »

Review of New ACT Paper on hESC-derived MSCs

advanced-cell-technology-150x1501

Advanced Cell Technology (ACT; $ACTC) has a new paper out on using human embryonic stem cells (hESC) to make MSCs with potentially powerful therapeutic potential. The paper, entitled Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties, was published in the journal Stem Cells and Development. What’s the scoop on this …

Review of New ACT Paper on hESC-derived MSCs Read More »

Interview with Robert Klein on CIRM’s Future

What does the future hold for CIRM? I asked former CIRM Board Chair and Prop 71 leader, Robert Klein, about that and more in the interview below. He also says some particularly exciting clinical trial and other developments in the stem cell field are coming soon. What got you excited for the very first time …

Interview with Robert Klein on CIRM’s Future Read More »

Big Changes Unfolding at Advanced Cell Technology (ACTC)

advanced-cell-technology

Stem cell biotech, Advanced Cell Technology (ACT; stock symbol ACTC), has started off 2014 with indications that it is in a phase of rapid evolution. Some changes, such as today’s announced departure of now former CEO Gary Rabin (see my 2013 interview with him here), are already in the public domain, but other big developments …

Big Changes Unfolding at Advanced Cell Technology (ACTC) Read More »